what are the long term effects of glp 1 drugs Nutritional & Botanical Support For GLP-1 Activity GLP-1 Side Effects: 7 Important

Others: Roche, J&J, Sanofi, and AZ have had GLP-1 efforts (some deprioritized) or new dual/triple agonists in development (e.g., Roches pipeline includes a dual agonist announced in 2024)

8 Cost The high cost of these medications is a barrier to many patients continuing them, with US list prices or $12,000-16,000 per year, and over $6500 a year at maximum discount

doi: 10.1016/j.neuroscience.2011.02.023

[DOI] [PMC free article] [PubMed] [Google Scholar] 118.Miller R.A., Chu Q., Xie J., Foretz M., Viollet B., Birnbaum M.J

The lead program is a once-monthly GLP-1 receptor agonist that Novo will initially develop in obesity and type 2 diabetes